Banque Pictet & Cie Sa
Source: SEC Form 13F · as of Mar 2026Banque Pictet & Cie Sa holds 12 biotech & pharma companies tracked by BioSniper, totaling $191.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$191.9M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Moderna, Inc. (MRNA)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| MRNAModerna, Inc. | 2,748,754 | $139.6M |
| GILDGILEAD SCIENCES, INC. | 202,253 | $28.2M |
| REGNREGENERON PHARMACEUTICALS, INC. | 9,893 | $7.6M |
| PCVXVaxcyte, Inc. | 61,846 | $3.6M |
| GPCRStructure Therapeutics Inc. | 49,367 | $2.4M |
| IMVTImmunovant, Inc. | 88,660 | $2.2M |
| APGEApogee Therapeutics, Inc. | 19,960 | $1.7M |
| ABVXAbivax SA | 15,040 | $1.7M |
| INCYIncyte Corp. | 17,455 | $1.6M |
| VKTXViking Therapeutics, Inc. | 48,492 | $1.6M |
| SLNOSOLENO THERAPEUTICS INC | 38,730 | $1.3M |
| JAZZJazz Pharmaceuticals plc | 2,000 | $378K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.